Overview

A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

Status:
COMPLETED
Trial end date:
2023-11-20
Target enrollment:
Participant gender:
Summary
The goal of this study is to learn what happens to MK-6552 in a person's body over time. Researchers will compare what happens to levels of MK-6552 in people's blood when it is taken with and without modafinil. Researchers also want to learn about the safety of MK-6552 taken with and without modafinil and if people tolerate it.
Phase:
PHASE1
Details
Lead Sponsor:
Merck Sharp & Dohme LLC
Treatments:
Modafinil